NCT02251873View on ClinicalTrials.gov

Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

March 31, 2002

Conditions
Healthy
Interventions
DRUG

TPV + RTV (low dose)

DRUG

TPV + RTV (high dose)

DRUG

ddl

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02251873 - Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers | Biotech Hunter | Biotech Hunter